Valuation: Kenvue Inc.

Market Cap 33.08B 29.38B 27.47B 25.04B 47.13B 3,185B 47.78B 332B 129B 1,622B 124B 121B 5,209B P/E 2026 *
18.1x
P/E 2027 * 15.8x
Enterprise Value 40.18B 35.68B 33.37B 30.41B 57.25B 3,868B 58.04B 404B 156B 1,970B 151B 148B 6,327B EV / Sales 2026 *
2.58x
EV / Sales 2027 * 2.48x
Free-Float
98.88%
Yield 2026 *
4.9%
Yield 2027 * 5%
1 day-2.49%
1 week-2.21%
Current month-2.49%
1 month-8.16%
3 months-10.92%
6 months-0.92%
Current year-0.17%
1 week 17.19
Extreme 17.19
18.08
1 month 17.19
Extreme 17.19
19.18
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 14/07/2025
Director of Finance/CFO 48 12/05/2026
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 59 08/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 A
Starboard Value LP
OtherCompany 0 0% -
9/28/26 A Free

Director

1,300 0.0001%
9/28/26 A Free

Director

1,300 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.49%-2.21%+8.64%-14.24% 33.92B
-0.92%-1.19%-6.03%-1.31% 337B
-2.03%-3.35%+1.47%-5.46% 229B
-2.38%-4.56%-8.63%-1.66% 132B
-0.93%-0.93%+6.99%+18.87% 68.01B
-3.04%-0.89%+19.38% - 46.35B
-2.29%-5.04%-27.61%-25.54% 46.05B
-2.78%-5.43%+4.63%-37.61% 33.56B
-3.17%-2.96%-23.44%-21.94% 32.4B
-1.29%-2.16%+8.42%+24.33% 20.15B
Average -2.13%-1.79%-1.62%-7.17% 97.89B
Weighted average by Cap. -1.74%-2.16%-2.93%-4.04%

Financials

2026 *2027 *
Net sales 15.6B 13.85B 12.95B 11.8B 22.22B 1,502B 22.53B 157B 60.66B 765B 58.55B 57.28B 2,456B 15.97B 14.18B 13.26B 12.09B 22.75B 1,537B 23.07B 160B 62.11B 783B 59.95B 58.65B 2,515B
Net income 1.83B 1.62B 1.52B 1.38B 2.6B 176B 2.64B 18.36B 7.11B 89.59B 6.86B 6.71B 288B 2.1B 1.87B 1.75B 1.59B 3B 202B 3.04B 21.12B 8.18B 103B 7.89B 7.72B 331B
Net Debt 7.1B 6.31B 5.9B 5.37B 10.12B 684B 10.26B 71.34B 27.62B 348B 26.66B 26.08B 1,118B 6.53B 5.8B 5.43B 4.94B 9.31B 629B 9.44B 65.64B 25.41B 320B 24.53B 23.99B 1,029B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
01/10/26 $17.22 -2.49% 22,208,533
30/09/26 $17.66 -1.40% 25,407,189
29/09/26 $17.91 +0.17% 19,194,868
28/09/26 $17.88 +0.45% 16,029,406
25/09/26 $17.80 +1.08% 12,581,826
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.22USD
Average target price
19.50USD
Spread / Average Target
+13.24%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock